Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and Anticancer Activities of Pyrazole–Thiadiazole-Based EGFR Inhibitors
Berkant Kurban, Begüm Nurpelin Sağlık, Derya Osmani̇ye, et al.
ACS Omega (2023) Vol. 8, Iss. 34, pp. 31500-31509
Open Access | Times Cited: 15

Showing 15 citing articles:

Synthesis and biological evaluation of 1-phenyl-tetrahydro-β-carboline-based first dual PRMT5/EGFR inhibitors as potential anticancer agents
Juan Zhang, Xuliang Liu, Na Sa, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116341-116341
Closed Access | Times Cited: 4
Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy
Mehlika Dilek Altıntop, İpek Ertorun, Gülşen Akalın Çiftçi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116698-116698
Closed Access | Times Cited: 4
Advancing drug discovery: Thiadiazole derivatives as multifaceted agents in medicinal chemistry and pharmacology
Benjamin Ayodipupo Babalola, Lekhnath Sharma, Olanike G. Olowokere, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117876-117876
Closed Access | Times Cited: 2
Path of Pyrazoles from Synthetic Factors to Anti-inflammatory Potential: A Review
Ketan Vashisht, Pooja Sethi, Anshul Bansal, et al.
Asian Journal of Chemistry (2024) Vol. 36, Iss. 6, pp. 1217-1231
Open Access | Times Cited: 1
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
Ketan R Hosamani, K. Hemalatha, Rohit Pal, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 1
One-Pot Multicomponent Synthesis of Novel Pyrazole-Linked Thiazolyl-Pyrazolines: Molecular Docking and Cytotoxicity Assessment on Breast and Lung Cancer Cell-lines
Ronak D. Kamani, Dipak K. Raval, Kirit B. Patel, et al.
Journal of Molecular Structure (2024), pp. 140295-140295
Closed Access | Times Cited: 1
Novel Pyrazolyl-Derived Zinc(Ii) and Cadmium(Ii) Complexes: Synthesis, Spectral Characterization, Single Crystal Insights, Hirshfeld Surface Analysis, and DNA Binding Studies
Lakshmi Krishnaa Suresh, Pramod Kumar Maniyampara, N. Mohan, et al.
(2024)
Closed Access
Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site Inhibitors
Wurood A. Shihab, Ammar A. Razzak Mahmood Kubba, Lubna H. Tahtamouni, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 38, pp. 6336-6356
Closed Access
PYRAZOLOPYRIMIDINES AS ANTICANCER AGENTS; SYNTHESES AND MODE OF ACTION (REVIEW ARTICLE)
Wafaa A. Zaghary, Tamer Nasr, Rania Abd El-Hameed, et al.
˜Al-œAzhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences (2024) Vol. 69, Iss. 1, pp. 62-107
Open Access
Pyrazolyl-derived zinc(II) and cadmium(II) complexes: Synthesis, spectral characterization, single crystal insights, Hirshfeld surface analysis, and in silico DNA interaction studies
Lakshmi Krishnaa Suresh, Pramod Kumar Maniyampara, N. Mohan, et al.
Inorganic Chemistry Communications (2024) Vol. 168, pp. 112811-112811
Closed Access
Novel s-Triazine Derivatives as Potential Anticancer Agents: Synthesis, DFT, DNA Binding, Molecular Docking, MD Simulation and in silico ADMET Profiling
Alia Mushtaq, Muhammad Moazzam Naseer
Journal of Molecular Structure (2024) Vol. 1322, pp. 140558-140558
Closed Access
Synthesis, Docking, and Dynamic Studies of New Pyrano‐[3,2‐e]‐Pyrazole Fused 1,2,4‐Triazolo‐[4,3‐c]‐pyrimidine Analogues as Anticancer Agents
N.S. Kumar, Ravi Kumar Ganta, Harihara Padhy, et al.
ChemistrySelect (2024) Vol. 9, Iss. 42
Open Access
Azole Derivatives: Cutting‐Edge Agents in Cancer Therapy
Anuradha Mehra, Amit Mittal, Rekha Sangwan
ChemistrySelect (2024) Vol. 9, Iss. 43
Closed Access
Recent progress on anti-cancer activity of thiadiazoles: A review
CR Santhosh, Sampath Chinnam, Nagaraju Kottam, et al.
Results in Chemistry (2024), pp. 101939-101939
Open Access
Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
Marwa I. Serag, Samar S. Tawfik, Hassan M. Eisa, et al.
Drug Development Research (2024) Vol. 86, Iss. 1
Closed Access
Page 1

Scroll to top